A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

A weight-maintaining hormone is essential for brain-signal transmission. New research is more closely linking obesity to ...

Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

Two Types. Confocal microscopy reveals α-synuclein (green) and lipids (red) in three adjacent inclusions (left and right). The white arrows point to Type I inclusions loaded with lipids. Blue ...

In the past two years, the U.S. Food and Drug Administration has approved two monoclonal antibody treatments to slow ...

“Alzheimer’s patients” suffer from loss of memory, which may cause them to forget people, places, and directions. It is an ...

There is no cure for the disease and the symptoms are currently irreversible, though there are treatments under development.

Scientists discovered a link between copper regulation and neurodegeneration, using the worm gene swip-10. Their findings suggest that restoring copper balance could offer new treatments for disorders ...

Discover promising biotech candidates and groundbreaking research offering new hope for treating mitochondrial diseases.

As a vetted Alzheimer’s Moonshot Community member, NeuroEM has collaborative access to a network of organizations contributing science and resources toward finding a cure for Alzheimer’s disease.

The study showed that the activation of these immune cells isn’t just a result of Alzheimer’s disease—it might actually help ...